a Cardiovascular Epidemiology and Genetics Research Group , IMIM (Hospital del Mar Medical Research Institute) , Barcelona , Catalonia , Spain.
b Universitat Pompeu Fabra (UPF) , Barcelona , Catalonia , Spain.
Epigenetics. 2017;12(10):909-916. doi: 10.1080/15592294.2017.1363951. Epub 2017 Nov 27.
Obesity is associated with increased risk of several diseases and has become epidemic. Obesity is highly heritable but the genetic variants identified by genome-wide association studies explain only limited variability. Epigenetics could contribute to explain the missing variability. The study aim was to discover differential methylation patterns related to obesity. We designed an epigenome-wide association study with a discovery phase in a subsample of 641 REGICOR study participants, validated by analysis of 2,515 participants in the Framingham Offspring Study. Blood DNA methylation was assessed using Illumina HumanMethylation450 BeadChip. Next, we meta-analyzed the data using the fixed effects method and performed a functional and pathway analysis using the Ingenuity Pathway Analysis software. We were able to validate 94 CpGs associated with body mass index (BMI) and 49 CpGs associated with waist circumference, located in 95 loci. In addition, we newly discovered 70 CpGs associated with BMI and 33 CpGs related to waist circumference. These CpGs explained 25.94% and 29.22% of the variability of BMI and waist circumference, respectively, in the REGICOR sample. We also evaluated 65 of the 95 validated loci in the GIANT genome-wide association data; 10 of them had Tag SNPs associated with BMI. The top-ranked diseases and functions identified in the functional and pathway analysis were neurologic, psychological, endocrine, and metabolic.
肥胖与多种疾病的风险增加有关,已成为一种流行疾病。肥胖具有高度遗传性,但全基因组关联研究中确定的遗传变异仅能解释有限的可变性。表观遗传学可能有助于解释这种缺失的可变性。本研究旨在发现与肥胖相关的差异甲基化模式。我们设计了一项基于 REGICOR 研究中 641 名参与者亚组的表观基因组全基因组关联研究,在弗雷明汉后代研究中对 2515 名参与者的分析进行了验证。使用 Illumina HumanMethylation450 BeadChip 评估血液 DNA 甲基化。接下来,我们使用固定效应方法对数据进行荟萃分析,并使用 Ingenuity Pathway Analysis 软件进行功能和途径分析。我们能够验证与体重指数(BMI)相关的 94 个 CpG 和与腰围相关的 49 个 CpG,位于 95 个基因座。此外,我们还新发现了 70 个与 BMI 相关的 CpG 和 33 个与腰围相关的 CpG。这些 CpG 分别解释了 REGICOR 样本中 BMI 和腰围变异性的 25.94%和 29.22%。我们还在 GIANT 全基因组关联数据中评估了 95 个验证基因座中的 65 个,其中 10 个具有与 BMI 相关的标记 SNP。功能和途径分析中排名最高的疾病和功能是神经、心理、内分泌和代谢。